Biotechnology Industry Cooperation Agreements

Shareholder Cooperation Agreement, effective as of August 11, 2023, by and among Jeremy Blank, Community Master Fund, LP and the Company (Gamida Cell Ltd., Filed With SEC on November 14, 2023)

Cooperation Agreement, dated as of October 31, 2023, by and among the Investors and the Company (MEI Pharma, Inc., Filed With SEC on November 1, 2023)

Cooperation Agreement, dated as of September (Aurinia Pharmaceuticals Inc., Filed With SEC on September 21, 2023)

Cooperation Agreement, dated April 13, 2023, by and among the Company and the Investor Group (Anika Therapeutics, Filed With SEC on April 13, 2023)

Form of Cooperation Agreement, dated as of September 2, 2022, by and between Tyme Technologies, Inc. and each of its current executive officers (TYME TECHNOLOGIES, INC., Filed With SEC on September 6, 2022)

Cooperation Agreement dated August 15, 2022, by and between PharmaCyte Biotech, Inc. and Iroquois Master Fund Ltd. and its affiliates (PharmaCyte Biotech, Inc., Filed With SEC on August 16, 2022)

Cooperation Agreement, dated as of June 15, 2022, by and among ARCA biopharma, Inc., Cable Car Capital LLC, the Funicular Fund LP, Funicular Funds, LP and Jacob Ma-Weaver (ARCA biopharma, Inc., Filed With SEC on June 21, 2022)

Co-operation Agreement, dated March 27, 2022, by and between Eagle Pharmaceuticals, Inc. and Acacia Pharma Group plc (Eagle Pharmaceuticals, Inc., Filed With SEC on March 28, 2022)

Amendment to Cooperation Agreement, dated as of August 5, 2021, by and among Athersys, Inc. and HEALIOS K.K. and Dr. Tadahisa Kagimoto (ATHERSYS, INC, Filed With SEC on November 15, 2021)

Amendment No. 1 to the Cooperation Agreement, dated September 2, 2021, by and between CytRx Corporation and Jerald A. Hammann (CYTRX CORP, Filed With SEC on September 9, 2021)

Cooperation Agreement, dated as of February 16, 2021, by and among Athersys, Inc. and HEALIOS K.K. and Dr. Tadahisa Kagimoto (ATHERSYS, INC, Filed With SEC on February 16, 2021)

Cooperation Agreement, dated August 21, 2020, by and between CytRx Corporation and Jerald A. Hammann (CYTRX CORP, Filed With SEC on August 24, 2020)

Cooperation Agreement, dated July 14, 2020, between the Company and Keith Murphy (ORGANOVO HOLDINGS, INC., Filed With SEC on July 15, 2020)

Cooperation and Support Agreement, dated as of February 27, 2020, by and among PDL BioPharma, Inc., Engine Capital, L.P. and its affiliates (PDL BIOPHARMA, INC., Filed With SEC on February 28, 2020)

Cooperation Agreement, effective as of January 13, 2020, between Catalyst Biosciences, Inc. and certain Investors specified therein (CATALYST BIOSCIENCES, INC., Filed With SEC on January 17, 2020)

Amended and Restated Information Sharing and Cooperation Agreement, effective as of December 28, 2018, by and between Immunovant Sciences Ltd. and Roivant Sciences Ltd (Health Sciences Acquisitions Corp, Filed With SEC on December 20, 2019)

Amended and Restated Information Sharing and Cooperation Agreement, effective as of June 7, 2019, by and between Dermavant Sciences Ltd. and Roivant Sciences Ltd (Dermavant Sciences Ltd, Filed With SEC on June 10, 2019)

Amendment No.1 to Information Sharing and Cooperation Agreement, dated as of May 24, 2019, by and between Roivant Sciences Ltd. and the Registrant (Myovant Sciences Ltd., Filed With SEC on May 24, 2019)

Cooperation Agreement, dated as of May 1, 2019, among Adverum Biotechnologies, Inc., The Sonic Fund II, L.P. and Lawrence Kam (Adverum Biotechnologies, Inc., Filed With SEC on May 2, 2019)

Cooperation Agreement, dated August 9, 2018, by and between Vernalis plc and Ligand Holdings UK Ltd (Ligand Pharmaceuticals Incorporated, Filed With SEC on August 9, 2018)

Amended and Restated Information Sharing and Cooperation Agreement, dated as of June 5, 2018, by and between the Registrant and Roivant Sciences Ltd (Axovant Sciences Ltd., Filed With SEC on August 7, 2018)

Cooperation Agreement, dated as of February 27, 2018, between the Company and Scopia (Acorda Therapeutics, Filed With SEC on February 28, 2018)

INFORMATIONSHARING AND COOPERATION AGREEMENT (Myovant Sciences Ltd., Filed With SEC on September 30, 2016)

Strategic Cooperation Agreement (KIWA BIO-TECH PRODUCTS GROUP CORP, Filed With SEC on November 10, 2015)

Co-operation Agreement (ACADIA PHARMACEUTICALS INC, Filed With SEC on November 5, 2015)

CONFIDENTIAL TREATMENT REQUESTED COOPERATION AGREEMENT (REGENXBIO Inc., Filed With SEC on August 17, 2015)

INFORMATION SHARING AND COOPERATION AGREEMENT (Axovant Sciences Ltd., Filed With SEC on May 11, 2015)

Clinical Supply and Cooperation Agreement BetweenRitter & RSM/Inalco CLINICAL SUPPLY AND COOPERATION AGREEMENT (also referred to as “CSCA”) BETWEEN (RITTER PHARMACEUTICALS INC, Filed With SEC on April 24, 2015)

Exhibit 1.1 Supplementary Agreement on New Drug Methionine Enkephalin Cooperation, dated August 6, 2014, between TNI BioTech, Inc. and Hubei Qianjiang Pharmaceutical Co., Ltd (Immune Therapeutics, Inc., Filed With SEC on August 13, 2014)

18 July 2014 ABBVIE INC and SHIRE PLC CO-OPERATION AGREEMENT Herbert Smith Freehills LLP 1 (AbbVie Inc., Filed With SEC on July 18, 2014)

COOPERATION AGREEMENT (IMMUNE PHARMACEUTICALS INC, Filed With SEC on June 21, 2012)

COOPERATION AGREEMENT (IMMUNE PHARMACEUTICALS INC, Filed With SEC on March 30, 2005)

Category

Industry

Companies

Contracts

Cooperation Agreements in the Biotechnology Industry